Effect of Glutamine on Reducing Myocardial Damage

Phase 3

• Conditions: on ST elevation myocardial infarction.; Acute coronary thrombosis not resulting in myocardial infarction; I24.0

• Registration Number: IRCT20151109024975N12
• Lead Sponsor: Sari University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 106

Inclusion Criteria

Age over 18 years
NSTEMI patients
Normal function of liver, renal system, pulmonary system and thyroid

Exclusion Criteria

Emergency patients
Serious water and electrolyte disorders
Unwillingness to co-operate with the patient
History of chronic lung, liver, kidney and thyroid diseases and heart failure
Age over 80 years
Pregnant and lactating women
Patients who are hypersensitive to glutamine or who are banned in any way by their administration of glutamine
Total Bilirubin more than 10 mg / dL
Creatinine clearance less than 30 ml / min
Absolute Absence of Intestinal Feeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
onST elevation myocardial infarction. Timepoint: After diagnosis of myocardial infarction without ST elevation, an increase in Troponin and CK-MB in the first three days of hospitalization. Method of measurement: TIMI score.

Secondary Outcome Measures

Name	Time	Method
Duration of admission to CCU. Timepoint: Duration of admission. Method of measurement: Patients follow up.;Mortality. Timepoint: Duration of admission. Method of measurement: Patients follow up.